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Problem & Signiﬁcance
●

Medication prior authorization (MPA) is a cost containment strategy.

●

MPA can obstruct patient care by denial of prescribed medication.

●

MPA process is unclear at this primary care clinic and creates barriers to
care.

●

MPA procedures at the clinic take provider time and resources away from
patient care.

Available Knowledge
●

Providers are often unaware MPAs are required

●

Health plans require disparate formats for MPAs

●

MPA denials are common

●

In 2018 91% of providers reported negative effects of MPA on patient
outcomes

●

MPAs place a large economic burden on primary care practices

●

MPAs delay patient access to medication

Rationale
Research shows workﬂow interventions can
increase the MPA process eﬃciency

A smartphrase in the electronic health record
(EHR) is integrated into the workﬂow

Improved documentation can reduce clinician
time spent on MPA

A smartphrase provides a standard location and
template for MPA documentation within the EHR

Purpose and Aims
The overarching purpose is to:
○ Optimize the MPA process at clinic with a simple
workﬂow-integrated intervention.
The speciﬁc aims are:
○ Assess baseline MPA practices
○ Develop and implement a smartphrase intervention called
MEDPRIORAUTH
○ Evaluate the eﬃcacy of and satisfaction with the intervention.

Methods - Context
●

The project took place at a nurse practitioner-led primary care practice,
serving 4000 patients in Vermont.

●

Staff includes eight nurse practitioners, one medical doctor, one registered
nurse, one medical assistant, and two administrative staff.

●

The clinic is independent, but contracts with a local hospital for the EHR and
billing.

Intervention
●

A pre-intervention staff survey assessed baseline MPA processes

●

The shared smartphrase MEDPRIORAUTH was created for MPA
documentation in the EHR

●

Laminated cards with a ﬂow chart for MPA and the name of the smartphrase
were placed near workstations

●

An explanation of how to use the smartphrase was emailed to staff

Study of the Intervention
● A post-intervention staff survey gathered information about:
○

The number of providers using the smartphrase

○

Barriers to using the smartphrase

○

General feedback about the smartphrase

● A rapid PDSA cycle was in place to modify the intervention.

Measures
●

Process Measures:
○

●

Percentage of pre- and post-surveys completed

Outcome Measures:
○

Percentage of providers using the smartphrase

○

Positive and negative feedback about the smartphrase

Analysis
●

●

Quantitative:
○

The number of stakeholders who participated in surveys

○

The number of stakeholders who used the intervention

Qualitative:
○

Descriptive survey responses from stakeholders

Methods - Ethical Considerations
●

IRB determination as “not research” status was obtained

●

Employees were informed that their participation in the project was voluntary
and every effort would be made to protect conﬁdentiality

Results
●

Quantitative
○
○
○
○

●

45.5% of staff responded to the pre- and post survey
40% of respondents used the smartphrase
4-8 administrative staff hours per week are spent on MPAs
Approximately 25-40% of MPAs are denied at the clinic

Qualitative
○
○
○
○

Providers and administrative staff are responsible for MPAs
Providers are often unaware of the need for MPAs
Providers modify their medication choices to avoid MPAs
Administrative staff, not providers receive MPA rejections

Discussion
●

Key Findings
○ Standardizing information can optimize the MPA process
○ Workﬂow integrated interventions are more likely to be adopted
○ Websites (such as formularies) or cheat sheets outside of the workﬂow
are less likely to be adopted.

●

Strengths
○ The smartphrase is integrated into the EHR and workﬂow
○ Using the smartphrase at the end of a SOAP note makes information
easy to locate
○ The workﬂow did not accrue any additional cost to the practice

Interpretation
●

The smartphrase streamlined the MPA process with improved
documentation and communication.

●

Workﬂow tasks regarding MPA documentation can be delegated to
non-provider staff.

●

The number of providers using the smartphrase was anticipated to be
greater.

●

Administrative staff MPA costs to the practice are estimated to be
$4160/year.

Limitations and Efforts to Minimize Limitations
●

●

Limits:
○

staff changes during the project

○

time constraints of the project

Efforts made to minimize limitations:
○

laminated cards with MPA education

○

Physical presence at the practice to introduce the intervention and
answer questions

.

Conclusions
●

Usefulness: An EHR smartphrase standardizes requirements for MPAs

●

Sustainability: the intervention does not interfere with the workﬂow

●

Potential to spread to other contexts: The smartphrase could be adapted for
prior authorization of referrals, procedures, and medical supplies.

●

Implication for practice and for further study: evaluate if there is a decrease
in MPA denials over a longer time period.

●

Suggested next steps: reduce barriers to use of the smartphrase with more
PDSA cycles.
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